Abstract:Background: Alcoholic fatty liver disease (AFLD) defines an important stage in the progression of alcoholic liver disease (ALD), which is a major cause of morbidity and mortality worldwide. Objective: To establish a mouse model of AFLD. Methods: Male C57BL/6 mice were divided into the following two groups: (i) a control group, which was allowed free access to food and water and (ii) an alcohol-treated group, which was administered a 15% (v/v) alcohol solution instead of water. After 8-9 months of treatment, serum biochemical indexes, histopathological changes, liver triglyceride content, iron storage, and ferritin light chain protein expression were measured using an automatic biochemical analyzer, hematoxylin-eosin (HE) staining, a commercially available kit, Prussian blue staining, and Western blot analysis, respectively. Results: Compared with the control group, the alcohol-treated group displayed increased levels of serum LDH, ALT, and AST, decreased levels of ALB, and no significant change in levels of TP. Additionally, increased levels of serum TG, T-CHO, and LDL and decreased levels of serum GLU and HDL were observed in the alcohol-treated mice. HE staining showed that lipid vacuolization occurred in the livers of alcohol-treated mice. The alcohol-treated mice also exhibited increased liver triglyceride content. Moreover, Prussian blue staining and Western blot analysis demonstrated that chronic alcohol administration caused iron overloading of the liver. Conclusions: Chronic administration of 15% (v/v) alcohol in the drinking water over 8-9 months caused AFLD in mice. Our results establish an AFLD model that represents a promising tool for the future study of the progression of ALD.

Advancements in the Alcohol-Associated Liver Disease Model

Noncoding RNAs in Alcoholic Liver Disease

Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges.

A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects

A Mini-Review of the Rodent Models for Alcoholic Liver Disease: Shortcomings, Application, and Future Prospects.

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis

Alcohol and the mechanisms of liver disease

A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Advances in research of alcoholic liver disease

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Development of alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell derived liver organoids

Establishment of an Alcoholic Fatty Liver Disease Model in Mice.

The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Challenge and direction of research on alcoholic liver disease

Liver regeneration and alcoholic liver disease

Animal Models of Chronic Liver Diseases.